Literature DB >> 6657770

Trypsin inhibitor effects on food intake and weight gain in Zucker rats.

C L McLaughlin, S R Peikin, C A Baile.   

Abstract

Decreased body weight and increased pancreas weight which occur in rats fed raw soybeans are thought to be due to the presence of trypsin inhibitors in the soybeans (SBTI). Since trypsin is postulated to be a negative feedback signal for cholecystokinin (CCK) secretion, SBTI may have these effects by increasing secretion of CCK. CCK is a putative satiety signal; thus, increased secretion of CCK could decrease food intake, and, if maintained over a period of time, body weight. In these experiments the effects of a trypsin inhibitor [N,N-dimethyl-carbamoyl 4-(4-guanidino-benzylyloxy)-phenyl acetate methane-sulfate (DGPM)]on feeding pattern were investigated in Zucker obese and lean rats. Administration of 25-200 mg/kg DGPM to 6-hr fasted rats decreased daily food intake by dose-dependently decreasing average meal size in both obese and lean rats, but the response was greater in obese rats. Administration of 100 mg/kg DGPM twice daily for 7 days decreased food intake and body weight in obese but not lean rats. Thus, these results suggest that decreased body weight associated with SBTI is due to decreased food intake partly as a result of increased secretion of the putative satiety peptide CCK.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657770     DOI: 10.1016/0031-9384(83)90071-9

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  6 in total

1.  Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.

Authors:  Kamal Albarazanji; Matthew Jennis; Cassandre R Cavanaugh; Wensheng Lang; Bhanu Singh; James C Lanter; James M Lenhard; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

2.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Satiety effects of a physiological dose of cholecystokinin in humans.

Authors:  R J Lieverse; J B Jansen; A A Masclee; C B Lamers
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

4.  Trypsin inhibitor from tamarindus indica L. seeds reduces weight gain and food consumption and increases plasmatic cholecystokinin levels.

Authors:  Joycellane Alline do Nascimento Campos Ribeiro; Alexandre Coellho Serquiz; Priscila Fabíola dos Santos Silva; Patrícia Batista Barra Medeiros Barbosa; Tarcísio Bruno Montenegro Sampaio; Raimundo Fernandes de Araújo Junior; Adeliana Silva de Oliveira; Richele Janaina Araújo Machado; Bruna Leal Lima Maciel; Adriana Ferreira Uchôa; Elizeu Antunes dos Santos; Ana Heloneida de Araújo Morais
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

Review 5.  Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?

Authors:  Vanessa Cristina Oliveira de Lima; Grasiela Piuvezam; Bruna Leal Lima Maciel; Ana Heloneida de Araújo Morais
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  A Trypsin Inhibitor from Tamarind Reduces Food Intake and Improves Inflammatory Status in Rats with Metabolic Syndrome Regardless of Weight Loss.

Authors:  Fabiana M C Carvalho; Vanessa C O Lima; Izael S Costa; Amanda F Medeiros; Alexandre C Serquiz; Maíra C J S Lima; Raphael P Serquiz; Bruna L L Maciel; Adriana F Uchôa; Elizeu A Santos; Ana H A Morais
Journal:  Nutrients       Date:  2016-09-27       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.